Primordial Dwarfism Registry

NCT ID: NCT04569149

Last Updated: 2025-10-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-03-11

Study Completion Date

2030-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this registry is to collect information on individuals with forms of microcephalic primordial dwarfism as well as related conditions. The study team hopes to learn more about these conditions and improve the care of people with them by establishing this registry.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The registry will enable detailed natural history studies of various forms of microcephalic primordial dwarfism as well as related conditions. The study team hopes that identification of risk factors will allow for preventative treatments and thus a better quality of life for individuals with these diagnoses.

This study is limited to chart review, after signed informed consent obtained. There will be no additional visits or time in clinic because of participation in this registry. This study involves only the collection and storage of data extracted from the medical record. Records that may be requested and reviewed as a part of this study include but may not be limited to: specialist evaluations, surgical reports, results of blood and urine tests, genetic testing, x-rays, CT/MRI/MRA imaging. There are no special procedures, visits, or expectations of the individual as a result of participation in this registry. No one will be asked to have any specific testing for the sole purposes of this research.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

MOPDII Meier-Gorlin Syndrome Saul-Wilson Syndrome Microcephalic Primordial Dwarfism IMAGe Syndrome RNU4atac-opathy (e.g MOPDI, Lowry-Wood Syndrome, and Roifman Syndrome) LIG4 Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals with MOPDII, Meier-Gorlin syndrome, IMAGe syndrome, RNU4atac-opathies (MOPDI/III, Roifman syndrome, Lowry-Wood syndrome), LIG4 syndrome, and other classified as well as unclassified types of microcephalic primordial dwarfism and related conditions, as diagnosed by a medical provider, are eligible for this registry.

Exclusion Criteria

* individuals without microcephalic primordial dwarfism or closely related conditions
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Potentials Foundation

UNKNOWN

Sponsor Role collaborator

Walking with Giants Foundation

UNKNOWN

Sponsor Role collaborator

Nemours Children's Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Angela Duker

Genetic Counselor/Coordinator of Skeletal Dysplasia Program

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Angela Duker, MS

Role: PRINCIPAL_INVESTIGATOR

Nemours

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nemours

Wilmington, Delaware, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Angela Duker, MS, CGC

Role: CONTACT

302-651-4181

Emily Longenecker, BS

Role: CONTACT

302-298-7978

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Angela Duker, MS, CGC

Role: primary

302-651-4181

Emily Longenecker, BS

Role: backup

302-298-7978

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MB001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study of Skeletal Disorders
NCT05031507 RECRUITING
Single Ventricle Outcome
NCT00308217 COMPLETED
RCDP Natural History Study
NCT04031287 UNKNOWN